The AAKP Center for Patient Engagement and Advocacy (CPEA) was created in 2014 to leverage AAKP’s increased profile and influence in the national public policy process, within the federal Legislative and Executive Branches. The Center works to expedite implementation of our National Strategy to vastly expand patient involvement in the key decisions that impact innovation, regulatory and payment decisions, and access to safe and approved treatments, diagnostics, and devices that improve patient care choice, quality of life, and overall health outcomes.

Additionally, as part of AAKP’s National Strategy, the Center for Patient Engagement and Advocacy works to engage, train, certify, and deploy kidney patients in ways that are the most effective at elevating the patient voice within Federal policy-making circles. This includes critical times when national legislation, health program implementation, regulations, or potential delays in the pharmaceutical approval process pose a concern to patient choice and access. AAKP continues to engage and encourage kidney patients and care partners to participate in substantive opportunities to raise their independent voice.

The AAKP thanks the following for their support of the Association’s Center for Patient Engagement and Advocacy:

SILVER